This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Companies Applying Genomics and Proteomics to Cancer. Pharmaceutical & Diagnostic Innovation 1, 60–63 (2003). https://doi.org/10.1007/BF03257265
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257265